Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RIZATRIPTAN vs ROCURONIUM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RIZATRIPTAN vs ROCURONIUM: Safety Overview

Metric RIZATRIPTAN ROCURONIUM
Total FAERS Reports 2,896 6,477
Deaths Reported 68 424
Death Rate 2.3% 6.5%
Hospitalizations 479 1,982
Average Patient Age 44.6 yrs 50.3 yrs
% Female Patients 77.2% 52.6%
FDA Approval Date Apr 14, 2023 Apr 12, 2017
Manufacturer Panacea Biotec Limited HF Acquisition Co LLC, DBA HealthFirst
Route ORAL INTRAVENOUS
Marketing Status Discontinued Discontinued